Adding a second antihypertensive medication appears to be more beneficial than increasing the dose of a single antihypertensive in reducing all-cause mortality cardiovascular outcomes in patients with cardiovascular disease (CVD). This was the main finding of a recent randomized trial that sought to determine the efficacy of high-dose angiotensin receptor blocker (ARB) therapy vs the addition of a calcium channel blocker (CCB) to a standard dose ARB in patients with CVD or type 2 diabetes.
In India, CVD has been cited to be the leading cause of death in both urban and rural areas, and its incidence is...
Log in or register for free to continue reading
Register Now For Free
Already Registered? Log In
Elderly hypertensive patients with cardiovascular disease may benefit from combination antihypertensive therapy
In India, CVD has been cited to be the leading cause of death in both urban and rural areas, and its incidence is...